Seagen Inc. (SGEN)

1 member of Congress has disclosed 4 trades in Seagen Inc. (SGEN) via STOCK Act filings. The most recent disclosure was a purchase by Josh Gottheimer on 17 October 2022. Aggregate disclosed activity totals roughly $32K in purchases (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for SGEN
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for SGEN

4 transactions
Compliance: 100%
Josh Gottheimer17 Oct 202210 Nov 2022PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer3 Aug 202020 Sept 2020PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer30 Apr 202013 May 2020PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer18 Feb 202016 Mar 2020PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$43.15B

Volume

19.39M

Beta

0.32

P/E Ratio

-57.19

Fundamentals

EPS

$-4.00

Div. Yield

-

Open

$228.93

Day Range

$228.74 – $228.96

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
David R. Epstein
IPO Date
2001-03-09
Website
www.pfizer.com

Seagen Inc. is a biotechnology firm focused on the development and global commercialization of innovative cancer treatments. Its portfolio features several key oncology therapeutics, including ADCETRIS, an antibody-drug conjugate (ADC) utilized for H...

Earnings

Recent Quarters

Q3 20231 Nov
EPS$-1.15
Miss 62.0%
Q2 20232 Aug
EPS$-1.13
Miss 44.9%
Q1 202327 Apr
EPS$-0.93
Miss 13.4%
Q4 202215 Feb
EPS$-0.80
Beat 21.6%
Q3 202227 Oct
EPS$-1.03
Miss 12.0%
Q2 202228 Jul
EPS$-0.73
Beat 11.0%
Q1 202228 Apr
EPS$-0.74
Beat 24.5%
Q4 20219 Feb
EPS$-0.95
Miss 20.3%
Q3 202128 Oct
EPS$-1.61
Miss 187.5%
Q2 202129 Jul
EPS$-0.47
Beat 22.9%
Q1 202129 Apr
EPS$-0.67
Miss 13.6%
Q4 202011 Feb
EPS$0.90
Beat 4.7%
Q3 202029 Oct
EPS$3.50
Beat 600.0%
Q2 202030 Jul
EPS$-0.54
Beat 6.9%
Q1 202030 Apr
EPS$-0.64
Beat 21.0%
Q4 20196 Feb
EPS$-0.22
Beat 51.1%
Q3 201929 Oct
EPS$-0.54
Miss 46.0%
Q2 201916 Jul
EPS$-0.24
Beat 38.5%
Q1 201925 Apr
EPS$-0.32
Beat 3.0%
Q4 20187 Feb
EPS$-0.57
Miss 46.1%
Q3 201825 Oct
EPS$-0.27
Beat 0.0%
Q2 201826 Jul
EPS$-0.18
Beat 47.1%
Q1 201826 Apr
EPS$-0.61
Miss 52.5%
Q4 20176 Feb
EPS$-0.41
Beat 4.7%
Q3 201726 Oct
EPS$-0.19
Beat 52.5%
Q2 201727 Jul
EPS$-0.39
Beat 9.3%
Q1 201727 Apr
EPS$-0.42
Miss 2.4%
Q4 20169 Feb
EPS$-0.39
Miss 14.7%
Q3 201627 Oct
EPS$-0.23
Beat 20.7%
Q2 201626 Jul
EPS$-0.23
Beat 30.3%
Q1 201628 Apr
EPS$-0.15
Miss 36.4%
Q4 20159 Feb
EPS$-0.18
Miss 5.9%
Q3 201529 Oct
EPS$-0.21
Miss 5.0%
Q2 201530 Jul
EPS$-0.38
Miss 65.2%
Q1 201530 Apr
EPS$-0.17
Beat 10.5%
Q4 201410 Feb
EPS$-0.22
Beat 15.4%
Q3 201430 Oct
EPS$-0.13
Beat 48.0%
Q2 201431 Jul
EPS$-0.14
Beat 36.4%
Q1 20141 May
EPS$-0.13
Beat 35.0%
Q4 201311 Feb
EPS$-0.13
Beat 43.5%
Q3 20135 Nov
EPS$-0.19
Beat 13.6%
Q2 201331 Jul
EPS$-0.06
Beat 66.7%
Q1 20137 May
EPS$-0.14
Beat 26.3%
Q4 201212 Feb
EPS$-0.09
Beat 30.8%
Q3 20127 Nov
EPS$-0.12
Beat 20.0%
Q2 20128 Aug
EPS$-0.15
Beat 0.0%
Q1 20128 May
EPS$-0.11
Beat 8.3%
Q4 201113 Feb
EPS$-0.32
Miss 10.3%
Q3 20113 Nov
EPS$-0.35
Beat 23.9%
Q2 20114 Aug
EPS$-0.45
Miss 15.4%
Q1 20115 May
EPS$-0.30
Beat 18.9%
Q4 20108 Feb
EPS$-0.34
Beat 10.5%
Q3 20101 Nov
EPS$-0.34
Beat 0.0%
Q2 201027 Jul
EPS$-0.08
Miss 300.0%
Q1 201027 Apr
EPS$0.11
Beat 189.5%
Q4 20099 Feb
EPS$-0.12
Beat 45.5%
Q3 200922 Oct
EPS$-0.21
Beat 16.0%
Q2 200923 Jul
EPS$-0.26
Beat 10.3%
Q1 200923 Apr
EPS$-0.33
Miss 13.8%
Q4 20085 Feb
EPS$-0.38
Miss 26.7%
Q3 200823 Oct
EPS$-0.27
Beat 0.0%
Q2 200822 Jul
EPS$-0.20
Beat 25.9%
Q1 200824 Apr
EPS$-0.22
Miss 22.2%
Q4 20077 Feb
EPS$-0.22
Beat 0.0%
Q3 200723 Oct
EPS$-0.22
Miss 46.7%
Q2 200725 Jul
EPS$-0.18
Miss 12.5%
Q1 200724 Apr
EPS$-0.16
Beat 5.9%
Q4 20066 Feb
EPS$-0.20
Beat 0.0%
Q3 200624 Oct
EPS$-0.17
Beat 15.0%
Q2 200625 Jul
EPS$-0.17
Beat 10.5%
Q1 200625 Apr
EPS$-0.21
Miss 16.7%
Q4 20057 Feb
EPS$-0.17
Beat 0.0%
Q3 200525 Oct
EPS$-0.15
Beat 37.5%
Q2 200526 Jul
EPS$-0.20
Beat 9.1%
Q1 200526 Apr
EPS$-0.18
Beat 28.0%
Q4 20048 Feb
EPS$-0.25
Beat 0.0%
Q3 200426 Oct
EPS$-0.40
Miss 5.3%
Q2 200427 Jul
EPS$-0.89
Miss 1.1%
Q1 200427 Apr
EPS$-0.24
Miss 33.3%
Q4 20033 Feb
EPS$-0.18
Beat 5.3%
Q3 200328 Oct
EPS$-0.17
Beat 19.1%
Q2 200329 Jul
EPS$-0.18
Beat 10.0%
Q1 200322 Apr
EPS$-0.20
Miss 5.3%
Q4 200230 Jan
EPS$-0.19
Beat 5.0%
Q3 200222 Oct
EPS$-0.17
Beat 32.0%
Q2 200223 Jul
EPS$-0.21
Beat 12.5%
Q1 200225 Apr
EPS$-0.20
Beat 28.6%
Q4 200129 Mar
EPS$-0.21
Q4 200131 Jan
EPS$-0.18
Beat 37.9%
Q2 200113 Aug
EPS$-0.18
Q1 200114 May
EPS$-0.46

1 politician traded within 30 days

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about SGEN

Which members of Congress have traded SGEN?
1 member of Congress has disclosed 4 trade in Seagen Inc. (SGEN) under the STOCK Act: Josh Gottheimer.
When was SGEN most recently disclosed by Congress?
The most recent SGEN disclosure was a purchase by Josh Gottheimer on 17 October 2022.
What is the total disclosed congressional trading volume for SGEN?
Members of Congress have disclosed approximately $32K in SGEN purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in SGEN?
This SGEN page updates as soon as new STOCK Act disclosures are filed for Seagen Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.